Durvalumab vs Valsartan

## Durvalumab vs Valsartan: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Valsartan**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Valsartan**: Angiotensin II type 1 receptor blocker.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Valsartan — 6 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Valsartan — C24H29N5O3.

**Molecular Weight**: Durvalumab — N/A; Valsartan — 435.5190 g/mol.

**Type**: Durvalumab — Antibody; Valsartan — Small molecule.